RxSight Inc (RXST): Market Cap to Revenue

Symbol and logo of brand RxSight Inc (RXST)

RxSight, Inc. (RXST) is developing a niche in Light Adjustable Lenses (LAL), which surgeons can fine-tune with a laser post-implantation. The business's profitability relies on the supply of innovative ophthalmological systems. The P/S ratio timeline demonstrates the market valuation of revenue, where the 1.80 mark reflects the latest data. Rapid demand for adjustable lenses is accelerating capital turnover, although current quotes already price in investor optimism.

RXST RxSight Inc P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for RxSight Corp (RXST)

- share price and consensus valuation forecast:
Price Performance Chart rxsight.com|RXST - Price Target Chart
- stock exchange capitalization data:
Market Valuation RxSight Corp|RXST - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share RxSight|RXST - Book Capitalization|Capitalization to Book Value Ratio rxsight.com|RXST - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient RxSight, Inc.|RXST - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio RxSight Ophthalmic|RXST - Company Aggregate Debts|Debts to Book Capitalization RxSight Corp|RXST - Company Long-Term Debt|Company Short-Term Debt RxSight|Intermediate Coverage Ratio rxsight.com
- earnings and multiples data:
RXST - Net Profit|Expected Net Profit RxSight, Inc.|RXST - Price to Earnings Ratio|Forward Price to Earnings Multiple RxSight Inc|RXST - Price/Earnings to Growth Multiple|EV/EBITDA Multiple RxSight Corp|RXST - Operating profit EBITDA|Net earnings per share for the last four quarters RxSight|RXST - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months rxsight.com|RXST - Earnings per share growth in current year|Expected earnings per share growth for next year RxSight, Inc.
- issuer revenue and sales details:
RXST - Revenue and Sales Volume|Company Expected Sales Volume rxsight.com|RXST - Price-to-Revenue Ratio|Market Cap to Projected Revenue RxSight Corp
General company analysis:RXST rxsight.com
Core merchandise of RxSight, Inc.

The P/S multiple reflects the market value of RxSight, Inc. (RXST) relative to its annual revenue, allowing for an assessment of the premium investors are willing to pay per unit of sales. By analyzing the current P/S level, one can determine the fairness of the asset's valuation, considering the business's protection via light system patents and high FDA certification barriers that limit competition in cataract surgery.

Competitors of RxSight, Inc.

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales axogeninc.com AXGN|Price-to-Revenue Ratio SI-BONE (SIBN)|Orthofix Medical (OFIX) - Price-to-Revenue Multiple|Bioventus Corp - Market Cap to Revenue|P/S Multiple OrthoPediatrics Corp KIDS|Treace Medical Concepts - P/S Multiple|Price-to-Revenue Coefficient blade.com SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint Neuro)|Price-to-Revenue Ratio Stereotaxis Corp|Market Cap to Revenue Neuronetics, Inc (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio Anika Therapeutics, Inc. ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical, Inc. - Market Cap to Sales Volume|xtantmedical.com (XTNT) - Price-to-Revenue Ratio|n1mtc.com - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue MODD|Market Cap to Revenue Ratio MYO (Myomo Inc.)|Price-to-Revenue Ratio Envoy Medical, Inc (COCH)|Price-to-Revenue Coefficient Vivos Therapeutics Inc|P/S Multiple NVNO (enVVeno Medical)|Price-to-Revenue Coefficient Sintx Technologies Inc (SINT)|Tenon Medical - P/S Multiple|Price-to-Revenue Multiple ReWalk Robotics (LFWD)|AMIX: P/S Multiple|INVO Fertility Corp - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue BBLG|AXNX (axonics.com) - Market Cap to Sales Volume|Market Cap to Revenue BIOL (BIOLASE)|DYNT (dynatronics.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple FNA (Paragon 28)|Price-to-Revenue Coefficient INVO Bioscience Inc. (INVO)